Nov 22 (Reuters) - EVOTEC SE EVTG.DE:
HAS TAKEN NOTICE OF STATEMENT MADE BY HALOZYME THERAPEUTICS INC. ON 22 NOVEMBER, STATING THAT IT HAS WITHDRAWN ITS NON-BINDING PROPOSAL TO ACQUIRE EVOTEC SE
MANAGEMENT BOARD AND SUPERVISORY BOARD CONTINUE TO HAVE STRONG CONVICTION IN COMPANY'S STANDALONE STRATEGY
Source text: ID:nEQ78hCRSa
Further company coverage: EVTG.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。